ProShare Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Buy |
|
|||||
|
2025
Q1 | $346K | Sell |
|
|||||
|
2024
Q4 | $577K | Buy |
|
|||||
|
2024
Q3 | $559K | Buy |
|
|||||
|
2024
Q2 | $429K | Sell |
|
|||||
|
2024
Q1 | $642K | Buy |
|
|||||
|
2023
Q4 | $766K | Buy |
|
|||||
|
2023
Q3 | $597K | Buy |
|
|||||
|
2023
Q2 | $293K | Buy |
|
|||||
|
2023
Q1 | $221K | Sell |
|
|||||
|
2022
Q4 | $291K | Buy |
|
|||||
|
2022
Q3 | $80K | Buy |
|
|||||
|
2022
Q2 | $53K | Sell |
|
|||||
|
2022
Q1 | $108K | Sell |
|
|||||
|
2021
Q4 | $212K | Sell |
|
|||||
|
2021
Q3 | $258K | Buy |
|
|||||
|
2021
Q2 | $289K | Buy |
|
|||||
|
2021
Q1 | $378K | Buy |
|
|||||
|
2020
Q4 | $1.08M | Buy |
|